基于多omics的黑色素瘤亚型表明不同的免疫和向治疗策略
Changchang Li1, Xiaoqiong Lin1, Jinhui Wang1
1Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, China.
Frontiers in immunology
|June 27, 2025
概括
这项研究根据多omics数据将黑色素瘤分为三种亚型. 这些亚型具有不同的免疫特征和治疗脆弱性,指导个性化的黑色素瘤治疗策略.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 黑色素瘤是一种复杂的癌症,具有多种分子和临床特征.
- 准确的分子分类对于预后和个性化黑色素瘤治疗至关重要.
研究的目的:
- 通过综合性多组学分析,定义皮肤黑色素瘤的分子亚型.
- 识别特定亚型的弱点和潜在的治疗目标.
主要方法:
- 癌症基因组图谱 (TCGA) 黑色素瘤数据的综合性多基因分析 (转录基因组,基因组,表观遗传,免疫).
- 无监督的聚类和机器学习来定义分子亚型.
- 功能性测试和in silico药物查用于脆弱性探索.
主要成果:
- 确定了三种不同的黑色素瘤亚型 (CS1,CS2,CS3) 具有独特的基因组,免疫和临床特征.
- CS2亚型在免疫学上是"热"的,具有高的TMB,对抗PD-1疗法反应良好.
- CS1和CS3亚型在免疫学上"冷",可能受益于HSP90或MEK抑制剂,其中COL11A2被确定为关键驱动因素.
结论:
- 呈现了一个精细的多omics黑色素瘤分类在不同的亚型.
- 为黑色素瘤的亚型特定治疗策略提供了一个框架.
- 确定了COL11A2作为免疫冷黑色素瘤亚型的潜在治疗点.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K


